Highly specific SARS-CoV-2 main protease (Mpro) mutations against the clinical antiviral ensitrelvir selected in a safe, VSV-based system
-
Published:2024-11
Issue:
Volume:231
Page:105969
-
ISSN:0166-3542
-
Container-title:Antiviral Research
-
language:en
-
Short-container-title:Antiviral Research
Author:
Rauch StefanieORCID,
Costacurta Francesco,
Schöppe HelgeORCID,
Peng Ju-Yi,
Bante DavidORCID,
Erisoez Ela Emilie,
Sprenger BernhardORCID,
He Xi,
Moghadasi Seyed Arad,
Krismer LauraORCID,
Sauerwein AnnaORCID,
Heberle Anne,
Rabensteiner Toni,
Wang DaiORCID,
Naschberger Andreas,
Dunzendorfer-Matt TheresiaORCID,
Kaserer TeresaORCID,
von Laer Dorothee,
Heilmann EmmanuelORCID
Funder
Austrian Science Fund